Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure enables strong binding to enzyme active sites, enhancing drug efficacy. Also employed in agrochemicals to improve stability and bioavailability of active ingredients. The trifluoromethyl group contributes to increased metabolic resistance and lipophilicity, making it valuable in optimizing pharmacokinetic properties in drug design.